JP2006502738A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006502738A5 JP2006502738A5 JP2004551403A JP2004551403A JP2006502738A5 JP 2006502738 A5 JP2006502738 A5 JP 2006502738A5 JP 2004551403 A JP2004551403 A JP 2004551403A JP 2004551403 A JP2004551403 A JP 2004551403A JP 2006502738 A5 JP2006502738 A5 JP 2006502738A5
- Authority
- JP
- Japan
- Prior art keywords
- oasl
- peptide
- seq
- expression
- protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 102100035473 2'-5'-oligoadenylate synthase-like protein Human genes 0.000 claims 45
- 101000597360 Homo sapiens 2'-5'-oligoadenylate synthase-like protein Proteins 0.000 claims 45
- 108090000765 processed proteins & peptides Proteins 0.000 claims 39
- 108090000623 proteins and genes Proteins 0.000 claims 17
- 230000027455 binding Effects 0.000 claims 15
- 238000000034 method Methods 0.000 claims 15
- 102000004169 proteins and genes Human genes 0.000 claims 14
- 150000001875 compounds Chemical class 0.000 claims 13
- 108091033319 polynucleotide Proteins 0.000 claims 13
- 102000040430 polynucleotide Human genes 0.000 claims 13
- 239000002157 polynucleotide Substances 0.000 claims 13
- 241001465754 Metazoa Species 0.000 claims 12
- 229920001184 polypeptide Polymers 0.000 claims 12
- 102000004196 processed proteins & peptides Human genes 0.000 claims 12
- 230000000694 effects Effects 0.000 claims 11
- 210000004027 cell Anatomy 0.000 claims 10
- 230000009261 transgenic effect Effects 0.000 claims 7
- 230000029279 positive regulation of transcription, DNA-dependent Effects 0.000 claims 5
- 108020001507 fusion proteins Proteins 0.000 claims 4
- 102000037865 fusion proteins Human genes 0.000 claims 4
- 230000003993 interaction Effects 0.000 claims 4
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 3
- 230000004913 activation Effects 0.000 claims 3
- 238000012258 culturing Methods 0.000 claims 3
- 210000003527 eukaryotic cell Anatomy 0.000 claims 3
- 239000012634 fragment Substances 0.000 claims 3
- 239000002773 nucleotide Substances 0.000 claims 3
- 125000003729 nucleotide group Chemical group 0.000 claims 3
- 238000012216 screening Methods 0.000 claims 3
- 238000013518 transcription Methods 0.000 claims 3
- 230000035897 transcription Effects 0.000 claims 3
- 230000004568 DNA-binding Effects 0.000 claims 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims 2
- 125000003275 alpha amino acid group Chemical group 0.000 claims 2
- 230000015556 catabolic process Effects 0.000 claims 2
- 230000000295 complement effect Effects 0.000 claims 2
- 238000006731 degradation reaction Methods 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 108020004999 messenger RNA Proteins 0.000 claims 2
- 210000001672 ovary Anatomy 0.000 claims 2
- 230000022532 regulation of transcription, DNA-dependent Effects 0.000 claims 2
- 101100134747 Mus musculus Oas1d gene Proteins 0.000 claims 1
- 101100134752 Mus musculus Oas2 gene Proteins 0.000 claims 1
- 101100518043 Mus musculus Oas3 gene Proteins 0.000 claims 1
- 101100518045 Mus musculus Oasl1 gene Proteins 0.000 claims 1
- 108091028043 Nucleic acid sequence Proteins 0.000 claims 1
- 241000283984 Rodentia Species 0.000 claims 1
- 230000000692 anti-sense effect Effects 0.000 claims 1
- 238000004113 cell culture Methods 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 230000035558 fertility Effects 0.000 claims 1
- 238000009396 hybridization Methods 0.000 claims 1
- 210000004408 hybridoma Anatomy 0.000 claims 1
- 230000036512 infertility Effects 0.000 claims 1
- 208000000509 infertility Diseases 0.000 claims 1
- 231100000535 infertility Toxicity 0.000 claims 1
- 150000007523 nucleic acids Chemical group 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 210000001236 prokaryotic cell Anatomy 0.000 claims 1
- 239000011780 sodium chloride Substances 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US38140802P | 2002-05-17 | 2002-05-17 | |
| PCT/US2003/015453 WO2004044124A2 (en) | 2002-05-17 | 2003-05-16 | Identification of oligoadenylate synthetase-like genes |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2006502738A JP2006502738A (ja) | 2006-01-26 |
| JP2006502738A5 true JP2006502738A5 (enExample) | 2006-06-22 |
Family
ID=32312405
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004551403A Withdrawn JP2006502738A (ja) | 2002-05-17 | 2003-05-16 | オリゴアデニレートシンテターゼ様遺伝子の同定 |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US7232678B2 (enExample) |
| EP (1) | EP1576142A2 (enExample) |
| JP (1) | JP2006502738A (enExample) |
| AU (1) | AU2003299505A1 (enExample) |
| CA (1) | CA2483693A1 (enExample) |
| WO (1) | WO2004044124A2 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2003248723A1 (en) * | 2002-06-19 | 2004-01-06 | Georgia State University Research Foundation, Inc. | Compositions and methods for viral resistance genes |
| US20050191649A1 (en) * | 2003-10-23 | 2005-09-01 | Illumigen Biosciences, Inc. | Detection of mutations in a gene associated with resistance to viral infection, OAS1 |
| WO2005040428A2 (en) | 2003-10-23 | 2005-05-06 | Illumigen Biosciences, Inc. | Detection of mutations in a gene associated with resistance to viral infection, oas1 |
| UA95446C2 (ru) * | 2005-05-04 | 2011-08-10 | Іллюміджен Байосайєнсіз, Інк. | Мутаци в генах oas1 |
| WO2007061690A2 (en) * | 2005-11-23 | 2007-05-31 | Illumigen Biosciences, Inc. | Novel pharmaceutical compositions for the treatment of virus infection and cancer |
| US20100246880A1 (en) * | 2009-03-30 | 2010-09-30 | Oxford J Craig | Method and apparatus for enhanced stimulation of the limbic auditory response |
| US20110104138A1 (en) * | 2009-11-03 | 2011-05-05 | Institut Pasteur | Use of the innate immunity gene oasl for preventing or treating infection with negative strand rna viruses |
| WO2019005856A1 (en) * | 2017-06-26 | 2019-01-03 | Arizona Board Of Regents On Behalf Of Arizona State University | CRISPR LOGIC CIRCUITS FOR SAFER AND CONTROLLABLE GENE THERAPIES |
| CN110951761A (zh) * | 2019-12-24 | 2020-04-03 | 扬州大学 | 一种检测鸡oasl启动子活性方法 |
| CN113384588B (zh) * | 2021-07-17 | 2022-03-08 | 南京农业大学 | 米非司酮在制备抗猪伪狂犬病毒药物中的应用 |
-
2003
- 2003-05-16 WO PCT/US2003/015453 patent/WO2004044124A2/en not_active Ceased
- 2003-05-16 CA CA002483693A patent/CA2483693A1/en not_active Abandoned
- 2003-05-16 AU AU2003299505A patent/AU2003299505A1/en not_active Abandoned
- 2003-05-16 JP JP2004551403A patent/JP2006502738A/ja not_active Withdrawn
- 2003-05-16 EP EP03799792A patent/EP1576142A2/en not_active Withdrawn
- 2003-05-16 US US10/439,741 patent/US7232678B2/en not_active Expired - Fee Related
-
2007
- 2007-06-17 US US11/764,220 patent/US20080081780A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Missler et al. | Neurexophilin binding to α-Neurexins: a single LNS domain functions as an independently folding ligand-binding unit | |
| JP2005046146A5 (enExample) | ||
| JP2010162016A5 (enExample) | ||
| Leng et al. | Organismal benefits of transcription speed control at gene boundaries | |
| JP2006515520A5 (enExample) | ||
| CA2479494A1 (en) | Compositions and methods associated with pro5725 and its use for the diagnosis of lung and colon tumor | |
| JP2005529610A5 (enExample) | ||
| JP2006502738A5 (enExample) | ||
| CA2335318A1 (en) | Nucleic acids encoding a g-protein coupled receptor involved in sensory transduction | |
| JP2004536585A5 (enExample) | ||
| JP2005518212A5 (enExample) | ||
| JP2004500013A5 (enExample) | ||
| JPH1066585A5 (enExample) | ||
| JP2005502344A5 (enExample) | ||
| KR950703057A (ko) | 글루카곤 수용체(glucagon receptors) | |
| JP2002536989A5 (enExample) | ||
| JP2005507648A5 (enExample) | ||
| JP2006512090A5 (enExample) | ||
| DE60129043D1 (de) | Identifizierung von genetischen determinanten der polymorphen cyp3a5 expression | |
| JP2003527844A5 (enExample) | ||
| JP2006518582A5 (enExample) | ||
| Darwish et al. | High‐throughput identification of conditional MHCI ligands and scaled‐up production of conditional MHCI complexes | |
| Traish et al. | Loss of expression of a 55 kDa nuclear protein (nmt55) in estrogen receptor-negative human breast cancer | |
| JP2007508020A5 (enExample) | ||
| CN117209600A (zh) | Ss-b结合蛋白、制备方法和应用 |